Management of In-Transit Metastases
Sign Up to like & getrecommendations! Published in 2022 at "Current Oncology Reports"
DOI: 10.1007/s11912-022-01216-0
Abstract: The purpose of this study is to discuss the current knowledge and future perspectives regarding the treatment options for in-transit metastases (ITM), along with the optimal algorithms for patients presenting with this adverse manifestation of… read more here.
Keywords: management transit; oncology; transit metastases; management ... See more keywords
ASO Author Reflections: Ultrasound Assessment of the Lymphatic Drainage Area in Melanoma Patients With In-Transit Metastases
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-020-09246-3
Abstract: Approximately 4% of patients with melanoma will experience in-transit metastases (ITMs). These patients are at high risk for further (distant) metastasis and have a grim prognosis. Multiple locoregional and systemic therapy options are available these… read more here.
Keywords: transit metastases; author reflections; reflections ultrasound; aso author ... See more keywords
Tumor Burden and Health-Related Quality of Life in Patients with Melanoma In-Transit Metastases
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers15010161
Abstract: Simple Summary Little research has investigated how patients with melanoma in-transit metastases (ITM) experience their health-related quality of life (HRQOL). This study aimed to investigate the association between sex, age, tumor burden, and HRQOL in… read more here.
Keywords: fact; patients melanoma; tumor burden; hrqol ... See more keywords